LA JOLLA, CA, June 15, 2023 (GLOBE NEWSWIRE) — GRI Bio, Inc. ( NASDAQ: GRI ) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T ("NKT") cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that Marc Hertz, Ph.D., Chief Executive Officer of GRI Bio, will present at the Healthcare Virtual Conference Pat II, presented by Maxim Group LLC and hosted by M-Vest on Thursday, June 22, 2023 at 12:00 PM ET.